Phase 1 Clinical Study of ^<123>I-IBF, a New Radioligand for Evaluating Dopamine D_2 Receptor with SPECT (II); Pharmacokinetics Study and Quantification in the Brain

• YONEKURA Yoshiharu

  Biomedical Imaging Research Center, Fukui Medical University

• SADATO Norihiro

  Biomedical Imaging Research Center, Fukui Medical University

• TSUCHIDA Tatsuro

  Department of Radiology, Fukui Medical University

• UEMATSU Hidemasa

  Department of Radiology, Fukui Medical University

• NAKAMURA Satoshi

  Biomedical Imaging Research Center, Fukui Medical University

• ONISHI Yoshihiro

  Nihon Medi-Physics Co., Ltd., Nishinomiya

• YAMAMOTO Kazutaka

  Department of Radiology, Fukui Medical University

• ISHII Yasushi

  Department of Radiology, Fukui Medical University

Bibliographic Information

Other Title

• ドパミンD_2受容体イメージング剤^<123>I-IBFの第1相臨床試験(第2報) : 脳内薬物動態およびその定量法の検討

Journal

• 核医学

  核医学 36 (2), 155-168, 1999-02-20

Keywords

• ^<123>I-IBF
• Dopamine D2 receptor
• Phase 1 study
• Pharmacokinetics
• Single photon emission computed tomography

Details

• CRID: 1572261549572090368
• NII Article ID: 10008493802
• NII Book ID: AN00038394
• ISSN: 00227854
• Web Site: https://search.jamas.or.jp/link/ui/1999157746
• Text Lang: ja
• Data Source:
  • CiNii Articles